Companies: 10,795·Total market cap: $144.5T
Standard BioTools Inc.

Standard BioTools Inc.

LABNASDAQHealthcare● Active
$0.83
$-0.32(-27.90%)
Market Cap$323654201
P/E Ratio—
52W High$1.72
52W Low$0.8087
SEC Filings

Standard BioTools Inc. (LAB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001162194 · LAB · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,002+
Total Filings
425
Latest Form
2026-06-08
Most Recent
2011
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001162194 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-16
Fiscal Year End
Mar 16, 2026
Accession No.
0001193125-26-108326
Primary Document
lab-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001162194 · Accession 0001193125-26-108326

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-06-08Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
425425
425
2026-06-08
View
8-KCurrent Report
FORM 8-K
2026-06-08
View
8-KCurrent Report
8-K
2026-06-05
View
8-KCurrent Report
8-K
2026-06-03
View
SDSD
SD
2026-05-29
View
8-KCurrent Report
8-K
2026-05-28
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-06
View
8-KCurrent Report
8-K
2026-05-05
View
ARSARS
ARS
2026-04-27
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-27
View
DEF 14AProxy Statement
DEF 14A
2026-04-27
View
8-KCurrent Report
8-K
2026-04-24
View
10-KAnnual Report
10-K
2026-03-16
View
Showing 1–15 of 470 filingsForm 4 / 144 hidden· 1002 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001162194  |  Exchange: NASDAQ · Healthcare

Standard BioTools Inc. (NASDAQ: LAB) has submitted 1,002+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2011. As a Healthcare sector company with CIK 0001162194, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Standard BioTools Inc.'s most comprehensive regulatory disclosure. The most recent Standard BioTools Inc. 10-K was filed on 2026-03-16 for fiscal year ending 2026. Historical LAB 10-K annual reports are available from 2016 through 2026.

Investors researching Standard BioTools Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
AVNS SEC Filings →CGEM SEC Filings →CBLL SEC Filings →BVS SEC Filings →CTKB SEC Filings →KIDS SEC Filings →VREX SEC Filings →SY SEC Filings →
→ LAB Financials→ LAB Earnings→ LAB Insider Trades

Frequently Asked Questions

LAB SEC Filings · 8 questions

Standard BioTools Inc. (LAB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,002+ filings and access original documents at no cost. Standard BioTools Inc.'s CIK is 0001162194.

LAB SEC filingsStandard BioTools Inc. SEC documentsfind LAB 10-K